Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: a randomized controlled trial. (2014)
Attributed to:
The Role of Cyclin-Dependent Kinase-9 Inhibition in Promoting the Resolution of Chronic Inflammation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/trf.12669
PubMed Identifier: 24796937
Publication URI: http://europepmc.org/abstract/MED/24796937
Type: Journal Article/Review
Volume: 54
Parent Publication: Transfusion
Issue: 10
ISSN: 0041-1132